# Impact of Daily Oral Cannabis Doses in Patients With Cancer

> **NCT06601218** · PHASE1 · RECRUITING · sponsor: **Shanna Babalonis, PhD** · enrollment: 80 (estimated)

## Conditions studied

- Cancer
- Cancers, Pain

## Interventions

- **DRUG:** Oral cannabis low THC
- **DRUG:** Placebo Comparator
- **DRUG:** Oral cannabis high THC
- **DRUG:** Oral cannabis THC/CBD

## Key facts

- **NCT ID:** NCT06601218
- **Lead sponsor:** Shanna Babalonis, PhD
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-17
- **Primary completion:** 2029-12-01
- **Final completion:** 2030-12-01
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2025-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06601218

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06601218, "Impact of Daily Oral Cannabis Doses in Patients With Cancer". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT06601218. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*